CEVA
CEVA, Inc.
CEVA has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CEVA overall, supported by stronger fundamentals and stronger modeled upside.
CEVA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
CEVA's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CEVA PE Valuation
CEVA has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
CEVA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CEVA, with profitability improving. However, they disagree widely on these estimates.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
CEVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.74 | — |
| Q3 2026 | -$0.39 | +$0.07 |
| Q2 2026 | -$0.41 | +$0.01 |
| Q1 2026 | -$0.46 | -$0.18 |
| Q4 2025 | -$0.44 | -$0.07 |
| Q3 2025 | -$0.46 | -$0.32 |
| Q2 2025 | -$0.42 | -$0.13 |
| Q1 2025 | -$0.28 | +$0.25 |
| Q4 2024 | -$0.37 | +$0.14 |
CEVA is still losing money, but far less than before: $0.39 per share over the past year, against $1.34 at its worst in mid-2023.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CEVA in the latest year-over-year earnings comparison.
CEVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $29.1M | +2.4% |
| Q2 2026 | $29M | +13% |
| Q1 2026 | $27M | +11% |
| Q4 2025 | $31.3M | +7.1% |
| Q3 2025 | $28.4M | +4.3% |
| Q2 2025 | $25.7M | -9.7% |
| Q1 2025 | $24.2M | +9.8% |
| Q4 2024 | $29.2M | +21% |
CEVA's revenue has grown year over year for five quarters in a row: $29M last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -4.8 points |
| Q2 2026 | -7.2% | +10 points |
| Q1 2026 | -19% | -0.8 points |
| Q4 2025 | -1.3% | -1.5 points |
| Q3 2025 | -7.3% | +2.3 points |
| Q2 2025 | -17% | -17 points |
| Q1 2025 | -18% | +4.4 points |
| Q4 2024 | 0.3% | +12 points |
CEVA's operating margin was −12% last quarter, down 4.8 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over CEVA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CEVA on profitability, with a higher operating margin.
CEVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $434K | +$6.7M |
| Q2 2026 | $5.2M | +955% |
| Q1 2026 | -$7.2M | +$515K |
| Q4 2025 | $7.2M | +3.1% |
| Q3 2025 | -$6.3M | -$6.3M |
| Q2 2025 | $492K | -72% |
| Q1 2025 | -$7.7M | +$539K |
| Q4 2024 | $7M | +73% |
CEVA has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
CEVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -42.2x | Net Cash |
| Q3 2022 | -8.0x | Net Cash |
| Q2 2022 | -2.0x | Net Cash |
| Q1 2022 | -3.5x | Net Cash |
| Q4 2021 | -3.5x | Net Cash |
| Q3 2021 | -3.3x | Net Cash |
| Q2 2021 | -3.2x | Net Cash |
| Q1 2021 | -10.5x | Net Cash |
CEVA has more cash than debt.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CEVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 25.4 | Neutral |
CEVA's weekly RSI is 43 (neutral) and its Stochastic is 25 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CEVA PE vs Technology Sector
| Metric | CEVA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CEVA has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
CEVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.7 | 14% below |
| 20 week MA | $32.6 | 19% below |
| 50 week MA | $29.4 | 11% below |
| 100 week MA | $27.7 | 4.9% below |
| 200 week MA | $25.7 | 2.3% above |
CEVA has stronger trend alignment. CEVA is above 1 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CEVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.1 | $42.2 | +56% |
| 2021 | $42.2 | $44.4 | +5.1% |
| 2022 | $44.4 | $25.9 | -42% |
| 2023 | $25.9 | $22.7 | -12% |
| 2024 | $22.7 | $32.4 | +43% |
| 2025 | $32.4 | $21.7 | -33% |
| 2026 YTD | $21.7 | $26.3 | +21% |
CEVA has finished lower in three of the last six years. It's up 21% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CEVA on returns for 2026, with the stronger performance.